Skip to content

Clinical trials

Coronary Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Country / region: Taiwan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20081
20092
20102
20111
20122
20192
20201
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status7
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital4
Chang Gung University of Science and Technology2
GlaxoSmithKline2
Abbott Medical Devices1
Amgen1
AstraZeneca1
Cathay General Hospital1
Chinese University of Hong Kong1
Far Eastern Memorial Hospital1
JuFeng, Hsiao1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease20
Coronary Artery Disease5
Cardiovascular Diseases4
Atherosclerosis3
Heart Diseases3
Acute Coronary Syndrome2
Myocardial Ischemia2
Arrhythmias, Cardiac1
Atrial Fibrillation1
Brain Ischemia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.